Practical use of hepatitis C and B molecular tools : Belgian Guidelines
| Journal | Volume 68 - 2005 |
| Issue | Fasc.3 - Symposium |
| Author(s) | M. Adler, P. Goubau, G. Leroux-Roels, D. Sprengers, J.-M. Pawlotsky |
| Full article |
 VIEW FREE PDF |
| (1) Department of Gastroenterology and Hepatopancreatology, Hôpital Erasme, ULB, Brussels ; (2) AIDS Reference Laboratory, Université Catholique de Louvain, Brussels ; (3) Centre for Vaccinology, Ghent University and Hospital, Ghent ; (4) Division of Hepatogastroenterology, St Augustinus Ziekenhuis, Wilrijk ; (5) Department of Virology, INSERM U635, Hôpital Henri Mondor, Université Paris 12, Créteil, France. |
|
This article discusses the use of virologic assays in the diagnosis and management of hepatitis C virus (HCV) and hepatitis B (HBV)infection. The use of virologic tests has become essential in the management of HCV and HBV infection to diagnose viral infection, guide treatment decisions, and assess the virologic response to antiviral therapy. The continuing development of test systems accompanied by new antiviral drugs and novel therapeu- tic approaches should lead to an optimization of the treatment of HCV infection. Molecular methods for viral testing have become an integral part of the diagnostic and therapeutic management of infections with hepatitis C virus (HCV) and hepatitis B virus (HBV). (Acta gastroenterol. belg., 2005, 68, 308-313). |
|
© Acta Gastro-Enterologica Belgica. |
